Serum insulin, insulin resistance, &beta;-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: A community-based study in Kinmen, Taiwan

doi:10.3748/wjg.v11.i45.7159

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2807)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

264

HTML

2119

Figures (1-2)

213

Tables (1-2)

211

Sum=2807

Dec 7, 2005 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2005; 11(45): 7159-7164
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7159

Table 1 Crude and age-adjusted odds ratios of baseline-associated factors of GSD among type 2 diabetics in Kinmen

	GSD (yes vs no)
	Male				Female
	Crude OR (95%CI)		Age-adjusted OR (95%CI)		Crude OR (95%CI)		Age-adjusted OR (95%CI)
Age (≥65 vs ＜65 yr)	3.14	(1.32-7.47)^a	-	-	2.25	(1.04-4.90)^a	-	-
Type 2 diabetes (known vs new cases)	0.90	(0.34-2.39)	0.87	(0.32-2.34)	1.44	(0.68-3.02)	1.46	(0.68-3.13)
FPG (≥11.1 vs ＜11.1 mmol/L)	2.12	(0.70-6.37)	1.95	(0.64-5.94)	1.24	(0.50-3.07)	1.49	(0.59-3.79)
SBP (≥140 vs ＜140 mmHg)	1.70	(0.73-3.97)	1.50	(0.63-3.56)	2.59	(1.23-5.46)^a	1.99	(0.92-4.31)
DBP (≥90 vs ＜90 mmHg)	1.44	(0.62-3.35)	1.57	(0.67-3.73)	1.12	(0.52-2.42)	1.21	(0.55-2.67)
Obesity (yes vs no)	2.04	(0.85-4.88)	2.00	(0.83-4.83)	2.97	(1.30-6.83)^a	2.88	(1.24-6.70)^a
Central obesity (yes vs no)	2.76	(1.13-6.77)^a	2.36	(1.01-5.97)	1.85	(0.68-5.02)	1.47	(0.53-4.09)
Cholesterol (≥5.17 vs ＜5.17 mmol/L)	1.02	(0.19-1.91)	0.88	(0.18-1.09)	0.92	(0.45-1.88)	0.85	(0.41-1.77)
Triglyceride (≥2.24 vs ＜2.24 mmol/L)	1.92	(0.12-2.36)	1.61	(0.13-2.84)	1.43	(0.20-2.46)	1.35	(0.15-1.96)
BUN (≥7.14 vs ＜7.14 mmol/L)	0.44	(0.16-1.25)	0.38	(0.13-1.09)	1.65	(0.75-3.61)	1.30	(0.58-2.93)
Uric acid (high vs normal)	0.30	(0.09-1.06)	0.29	(0.08-1.03)	1.61	(0.77-3.38)	1.12	(0.51-2.48)
AST (≥40 vs ＜40 U/L)	1.05	(0.08-5.72)	0.60	(0.07-5.31)	3.68	(1.01-9.32)^a	3.93	(1.04-10.89)^a
ALT (≥40 vs ＜40 U/L)	1.09	(0.19-4.33)	1.09	(0.21-5.61)	2.00	(0.67-6.02)	2.20	(0.71-6.85)
Serum insulin (2^ndvs 1^st quartile)	0.29	(0.06-1.33)	0.30	(0.06-1.39)	1.39	(0.44-4.40)	1.68	(0.52-5.45)
(μU/mL) (3^rdvs 1^st quartile)	0.61	(0.19-2.00)	0.56	(0.17-1.86)	2.05	(0.71-5.88)	2.20	(0.75-6.45)
(4^thvs 1^st quartile)	0.61	(0.18-2.03)	0.65	(0.20-2.17)	5.38	(2.14-13.48)^a	5.32	(2.08-13.64)^a
Log HOMA IR (2^ndvs 1^st quartile)	0.61	(0.19-2.00)	0.60	(0.18-1.99)	1.17	(0.38-3.57)	1.65	(0.52-5.29)
(3^rdvs 1^st quartile)	0.58	(0.06-1.29)	0.49	(0.06-1.36)	2.60	(1.02-6.64)^a	2.66	(1.02-6.94)^a
(4^thvs 1^st quartile)	0.63	(0.19-2.08)	0.60	(0.18-2.01)	2.60	(1.01-6.66)^a	2.59	(1.01-6.76)^a
Log HOMA β-cell (2^ndvs 1^st quartile)	1.16	(0.35-3.80)	1.27	(0.38-4.25)	0.35	(0.08-1.55)	0.45	(0.10-2.03)
(3^rdvs 1^st quartile)	0.52	(0.11-2.43)	0.51	(0.11-2.39)	0.16	(0.02-1.23)	0.17	(0.02-1.35)
(4^thvs 1^st quartile)	0.25	(0.03-2.97)	0.22	(0.03-1.73)	0.17	(0.02-1.28)	0.16	(0.02-1.21)

^aP＜0.05.

Citation: Liu CM, Tung TH, Tsai ST, Liu JH, Tsai YK, Chen VTK, Tam TN, Lu HF, Wang KK, Hsu CT, Shih HC, Chan DC, Chou P. Serum insulin, insulin resistance, β-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: A community-based study in Kinmen, Taiwan. World J Gastroenterol 2005; 11(45): 7159-7164
URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7159.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7159